Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- diabetes mellitus 1. typu imunologie prevence a kontrola terapie MeSH
- lidé MeSH
- NKT buňky imunologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Invariant natural killer T (iNKT) cells are CD1d-restricted T cells with regulatory functions. iNKT cells are numerically and functionally deficient in experimental models of type 1 diabetes mellitus (T1DM). Moreover, various experimental strategies correcting the defect of or stimulating iNKT cells prevent T1DM. Here, we review the data on the role of iNKT cells in the development of T1DM and discuss indications, obstacles and prospects of the use of iNKT cell manipulations in the prevention and treatment of human T1DM.
Zobrazit více v PubMed
J Autoimmun. 2004 Dec;23(4):293-300 PubMed
Immunity. 2010 Apr 23;32(4):457-67 PubMed
Nat Rev Immunol. 2010 Jul;10(7):501-13 PubMed
Curr Opin Immunol. 2008 Jun;20(3):358-68 PubMed
J Exp Med. 1995 May 1;181(5):1923-7 PubMed
Nat Med. 2001 Sep;7(9):1052-6 PubMed
J Exp Med. 1998 Apr 6;187(7):1047-56 PubMed
J Immunol. 2002 Jun 15;168(12):6007-11 PubMed
Nature. 1998 Jan 8;391(6663):177-81 PubMed
J Immunol. 2003 Aug 15;171(4):2142-53 PubMed
Eur J Immunol. 2002 Dec;32(12):3657-66 PubMed
Nat Rev Immunol. 2011 Feb;11(2):131-42 PubMed
Physiol Rev. 2011 Jan;91(1):79-118 PubMed
J Exp Med. 2000 Sep 4;192(5):741-54 PubMed
J Immunol. 2001 Mar 15;166(6):3749-56 PubMed
Nat Immunol. 2010 Mar;11(3):197-206 PubMed
J Exp Med. 2001 Dec 17;194(12):1801-11 PubMed
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13838-43 PubMed
Lancet. 1986 Jul 19;2(8499):119-24 PubMed
Int Rev Immunol. 2007 Jan-Apr;26(1-2):49-72 PubMed
J Exp Med. 2001 Dec 17;194(12):1789-99 PubMed
J Exp Med. 2008 Nov 24;205(12):2727-33 PubMed
J Clin Invest. 2008 Oct;118(10):3390-402 PubMed
J Exp Med. 2005 Nov 7;202(9):1279-88 PubMed
J Exp Med. 2002 Mar 4;195(5):637-41 PubMed
Eur J Immunol. 1996 Dec;26(12):2989-98 PubMed
J Immunol. 2004 May 15;172(10):5908-16 PubMed
Nat Rev Immunol. 2003 Mar;3(3):189-98 PubMed
Annu Rev Immunol. 2007;25:297-336 PubMed
Clin Cancer Res. 2002 Dec;8(12):3702-9 PubMed
Scand J Immunol. 2006 Nov;64(5):531-5 PubMed
Clin Exp Immunol. 2007 Apr;148(1):1-16 PubMed
J Exp Med. 2000 Jun 5;191(11):1895-903 PubMed
Eur J Immunol. 2004 Jun;34(6):1723-32 PubMed
J Immunol. 2002 Apr 1;168(7):3251-8 PubMed
J Clin Invest. 2002 Jan;109(1):131-40 PubMed
Curr Opin Immunol. 2011 Dec;23(6):739-45 PubMed
J Leukoc Biol. 2007 Mar;81(3):654-62 PubMed
Semin Immunol. 2010 Apr;22(2):68-78 PubMed
Nat Genet. 2001 Jan;27(1):68-73 PubMed
Nat Rev Immunol. 2005 Jan;5(1):31-42 PubMed
Hum Immunol. 2009 Apr;70(4):262-8 PubMed
Trends Immunol. 2004 Sep;25(9):471-6 PubMed
J Immunol. 2005 Feb 15;174(4):1954-61 PubMed
Diabet Med. 1994 Apr;11(3):299-303 PubMed
J Immunol. 2001 Jan 1;166(1):662-8 PubMed
Diabetes Care. 2002 Oct;25(10):1818-23 PubMed
Cytokine. 2011 Mar;53(3):263-70 PubMed
J Exp Med. 2011 Apr 11;208(4):729-45 PubMed
Diabetes Metab Res Rev. 2009 Nov;25(8):691-3 PubMed
J Clin Invest. 1995 Sep;96(3):1506-11 PubMed
J Immunol Methods. 2001 Jan 1;247(1-2):61-72 PubMed
Curr Opin Immunol. 2003 Dec;15(6):683-9 PubMed
Immunity. 2002 Dec;17(6):725-36 PubMed
J Immunol. 2007 Feb 1;178(3):1415-25 PubMed
Lancet. 2001 Jul 21;358(9277):221-9 PubMed
J Immunol. 2004 Sep 1;173(5):3112-8 PubMed
J Immunol Methods. 2004 Feb 15;285(2):197-214 PubMed
Semin Immunol. 2011 Jun;23(3):182-94 PubMed
J Immunol. 2006 Sep 15;177(6):3695-704 PubMed
Nat Rev Immunol. 2004 Mar;4(3):231-7 PubMed
Clin Immunol. 2011 Aug;140(2):117-8 PubMed
N Engl J Med. 2002 May 30;346(22):1692-8 PubMed
J Immunol. 2005 Aug 15;175(4):2091-101 PubMed
Curr Opin Immunol. 2011 Dec;23(6):746-53 PubMed
J Immunol. 2005 Oct 1;175(7):4458-64 PubMed
J Exp Med. 1998 Nov 16;188(10):1831-9 PubMed
Eur J Immunol. 2011 Dec;41(12):3574-85 PubMed
Immunol Cell Biol. 2009 May-Jun;87(4):315-23 PubMed
Nat Med. 2003 Sep;9(9):1202-8 PubMed
J Clin Invest. 2002 Sep;110(6):793-800 PubMed
J Exp Med. 2007 May 14;204(5):995-1001 PubMed
Diabet Med. 2006 Oct;23(10):1145-50 PubMed
J Exp Med. 2001 Aug 6;194(3):313-20 PubMed
J Immunol. 2006 Dec 15;177(12):8338-47 PubMed
J Immunol. 2005 Feb 1;174(3):1196-204 PubMed
Semin Immunol. 2011 Jun;23(3):214-9 PubMed
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6777-82 PubMed
Diabetes. 1997 Apr;46(4):572-82 PubMed
Immunity. 2010 Apr 23;32(4):468-78 PubMed
Immunology. 2007 Sep;122(1):1-14 PubMed
Science. 1997 Nov 28;278(5343):1626-9 PubMed
J Clin Immunol. 2008 Nov;28(6):677-84 PubMed
Nat Med. 2001 Sep;7(9):1057-62 PubMed
Immunol Cell Biol. 2004 Jun;82(3):247-52 PubMed
Diabetes. 2004 May;53(5):1303-10 PubMed
J Clin Invest. 2003 Oct;112(8):1211-22 PubMed
J Immunol. 2003 Oct 15;171(8):4439-46 PubMed
Diabetes. 2008 Oct;57(10):2693-7 PubMed